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ABSTRACT 
Type III secretion systems are complex 
nanomachines used for injection of proteins from 
Gram-negative bacteria into eukaryotic cells. 
While they are assembled when the environmental 
conditions are appropriate, they only start 
secreting upon contact with a host cell. Secretion 
is hierarchical: first, the pore-forming translocators 
are released, next, effector proteins are injected. 
Hierarchy between these protein classes is 
mediated by a conserved gate-keeper protein, 
MxiC in Shigella. As its molecular mechanism of 
action is still poorly understood, we used its 
structure to guide site-directed mutagenesis and 
dissect its function. We identified mutants 
predominantly affecting all known features of 
MxiC regulation: secretion of translocators, MxiC 
and/or effectors. Using molecular genetics we then 
mapped at which point in the regulatory cascade 
the mutants were affected. Analysis of some of 
these mutants led us to a set of electron 
paramagnetic resonance experiments that provide 
evidence that MxiC interacts directly with IpaD. 
We suggest how this interaction regulates a switch 
in its conformation that is key to its functions. 
INTRODUCTION 
Type III secretion systems (T3SSs) are 
central devices in the virulence of many major 
Gram-negative bacterial pathogens of humans, 
animals and plants. They translocate virulence 
proteins into the membranes and cytoplasm of 
eukaryotic host cells to manipulate them during 
infection. T3SSs are key to the virulence of enteric 
pathogens such as E. coli, Salmonella and Shigella 
species.  
Shigella species are the etiological agent 
of bacillary dysentery in humans. The Shigella 
T3SS consists of a cytoplasmic portion and a 
transmembrane region traversing both bacterial 
membranes, into which a hollow needle, made of 
MxiH, is embedded protruding from the bacterial 
surface (2). Physical contact with eukaryotic host 
cells activates the secretion system, which initiates 
secretion and leads to creation of a pore, formed 
by the bacterial proteins IpaB and IpaC, in host-
cell membranes (3). The effectors are translocated 
through the needle (4) and pore channels, to 
facilitate host cell invasion (3). The needle tip 
complex (TC), which contains IpaD and IpaB, is 
the host cell sensor and transforms itself into the 
translocation pore (5) via addition of IpaC upon 
secretion activation (6,7). IpaD is hydrophilic and 
required for tip recruitment of the other two 
proteins, which are hydrophobic, and hence 
chaperoned by IpgC intrabacterially (8). The three 
proteins are collectively called the translocators. 
T3SSs are assembled, using a broadly 
conserved morphogenesis pathway (9), following 
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detection of environmental cues indicating entry 
into the host. In addition, virulence effectors 
acting late in the host cell manipulation cascade 
are only expressed once the presynthesised early 
effectors have been secreted at host cell contact. 
Most components and/or molecular mechanisms 
of these regulatory pathways diverge from one 
T3SS-carrying organism to another (10). Yet, one 
regulatory cascade is conserved, a process 
allowing hierarchical secretion of substrates, 
although the stages it covers vary: needle vs. 
translocator components in plant pathogens or 
translocators and then early effectors in animal 
ones (11). 
We focus here on how this cascade 
functions in animal pathogens. After T3SS 
assembly, effector secretion is prevented through 
the concerted action of surface TC proteins and 
regulators that control secretion from within the 
bacterial cytoplasm. The TC may prevent 
premature effector secretion by allosterically 
constraining the T3SS in a secretion “off” 
conformation without blocking the secretion 
channel (12-14). Upon physical contact of the TC 
with host cells, a signal, termed Signal 1, is 
transmitted via the TC (15) and needle (12,16) to 
the cytoplasm where it triggers secretion. Next, 
translocators are secreted to form the pore in the 
host cell membrane (3). Successful pore formation 
at the needle tip generates Signal 2, also 
transmitted via the needle, that allows inactivation 
or T3S-mediated removal of a conserved 
cytoplasmic regulatory protein, MxiC in Shigella 
(12,16). Third, early effector proteins are secreted 
and translocated into the host cell and late effector 
expression is activated (17). 
MxiC belongs to a class of “gate-keeper” 
proteins that is conserved among different type III 
secretion systems (18). They repress effector 
secretion in the absence of a secretion signal, but 
have different roles in translocator secretion, 
impairing it in a ΔmxiC mutant (12) while 
stimulating it in a Yersinia ΔyopN mutant (19). 
While gate-keepers are clearly involved in the 
cytoplasmic steps controlling T3SS secretion 
hierarchy upon activation, their mechanism of 
action remains unclear. 
The gate-keepers have conserved 
structures (20,21): after an N-terminal secretion 
signal and putative chaperone-binding domain 
(CBD), three α-helical X-bundles (domains 1-3; 
supplemental Fig. S1A-C) form a flat, elongated 
structure (21) typical for “hub proteins” regulating 
processes via interaction with multiple partners. In 
some species, gate-keepers are composed of two 
proteins where the second polypeptide covers the 
C-terminal X-bundle (domain 3; supplemental  
Fig. S1D-E (20)).  
MxiC is secreted by the type III secretion 
system (22). Its N-terminal 30 residues contain the 
secretion signal (23). Immediately thereafter is a 
domain similar to the chaperone-binding domain 
of Yersinia YopN (20,21). This domain is partially 
conserved (18) even though not every MxiC 
homologue has an identified chaperone. While this 
area is enriched in hydrophobic residues that 
mediate interactions with the chaperones, fewer 
hydrophobic residues are found in MxiC. 
Many type III secreted proteins are bound 
by a chaperone inside the bacterium. These 
chaperones have various roles, including 
stabilisation of their binding partners, aiding their 
secretion and mediation of secretion hierarchy 
(24). Several MxiC homologues bind to specific 
heterodimeric chaperones. For instance, Yersinia 
YopN binds to the SycN/YscB heterodimer 
(20,25). It wraps around its heterodimeric 
chaperone in a conformation similar to other 
effector/chaperone complexes (20). This domain is 
disordered in the absence of the chaperones. 
Interestingly, the first ~75 residues of MxiC are 
likely also disordered (21). Yet, so far no 
chaperone has been identified for MxiC (23). 
MxiC’s helix 9 of is a straight helix, while 
the structurally equivalent helix in YopN/TyeA is 
kinked into two smaller helices. The structure of 
the EPEC MxiC homolog, SepL, is also bent at an 
equivalent location (26). Thus, one face of the 
molecule is flat in MxiC, while it is concave in 
YopN/TyeA and SepL (21,26). Interestingly, this 
surface contains a negatively charged patch (E201, 
E276, E293; (21)) we showed is important for 
MxiC functions that involve IpaD (15). 
Furthermore, the Chlamydia hydrophobic 
translocator chaperone Scc3 binds to its gate-
keeper at the flat interface between domain 2 and 
3 (27), which the kink in the YopN/TyeA renders 
convex. Deane et al. (2008) already suggested this 
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structural difference between MxiC and 
YopN/TyeA could be a “conformational switch” 
and these new findings suggest it might allow the 
switch from hydrophilic to hydrophobic 
translocator secretion. 
To dissect MxiC’s interconnected 
functions we used site-directed mutagenesis. 
Mutant design was guided by the description of 
MxiC structure by Deane et al. (2008) and the 
sequence alignment of MxiC homologues by 
Pallen et al. (2005) (18). Our mutations (Fig. 1) 
focussed on the N-terminal non-crystallised region 
and domains 2 and 3 of the crystal structure (21). 
We identified mutants predominantly affecting all 
known features of MxiC regulation: secretion of 
translocators, MxiC and effectors. Using 
molecular genetics to map at which point in the 
regulatory cascade the mutants were affected we 
further dissected MxiC’s role. Analysis of some of 
these mutants led us to electron paramagnetic 
resonance (EPR) experiments that, together with 
phenotypic analysis of the mutants, provide 
evidence that MxiC’s conformation is regulated 
via a direct interaction with IpaD. 
RESULTS 
MxiC’s secretion signal is not required for 
promoting inducible translocator secretion 
A non-secretable form of MxiC lacking 
residues 2 to 30 is unable to prevent effector 
secretion (23). However, MxiC also regulates 
inducible translocator secretion (12). This had not 
yet been characterised when the mxiCΔNterm 
mutant was first described. We thus investigated 
whether MxiC’s two roles could be uncoupled. 
We generated a mxiCΔNterm mutant 
equivalent to that of Botteaux et al. (2009). In our 
hands, MxiCΔNterm was unstable: while wild-
type mxiC was induced to wild-type levels after 
addition of 25 µM IPTG, mxiCΔNterm was only 
expressed at similar levels after addition of 100 
µM IPTG. Furthermore, MxiCΔNterm seemed 
partially degraded (Fig. 2B). 
As previously described, MxiCΔNterm is 
not secreted after Congo red (CR) induction (Fig. 
2A and (23)) and effector proteins are leaked ((23) 
and data not shown). Furthermore, MxiCΔNterm 
was not secreted in a ΔipaB constitutive secreter 
background (supplemental Fig. S2), indicating 
deletion of the N-terminus affects its ability to 
become secreted. However, secretion of IpaB, 
IpaC and IpaD was unaffected in mxiCΔNterm: 
small differences between ΔmxiC/mxiC+ and 
mxiCΔNterm were not statistically significant (Fig. 
2A and C). Thus, MxiC’s ability to prevent 
effector secretion and to promote inducible 
translocator secretion are not coupled and only the 
former requires its secretion signal. 
MxiC’s C-terminus is essential 
The 11 C-terminal residues of the EPEC 
MxiC homolog, SepL, are required for regulation 
of effector secretion but not for translocator 
secretion (28). As a complementary experiment, 
we deleted the last 14 residues of MxiC (Fig. 1B), 
which are equivalent to the last eleven residues of 
SepL ((18) and supplemental Fig. S3). The 
resulting mxiCΔCterm mutant was stably 
expressed, but unable to complement ΔmxiC 
(supplemental Fig. S4): translocators were only 
weakly induced and effector proteins were leaked. 
In addition, MxiCΔCterm itself was only poorly 
secreted (supplemental Fig. S4), even in ΔipaB 
(supplemental Fig. S2). Therefore, unlike for 
SepL, MxiC’s C-terminus is essential.  
 
The putative chaperone-binding domain of 
MxiC regulates its secretion, and hence that of 
effectors 
The chaperone-binding domain of YopN has 
a chaperone-independent role in secretion 
regulation (29). We thus wondered whether 
MxiC’s putative chaperone-binding domain is 
required for its function. First, we deleted the 
whole CBD (Fig. 1A) to generate mxiCΔCBD, 
lacking residues 32-72). This construct was stably 
expressed, but leaked and only weakly secreted 
upon CR induction (Fig. 3A). Interestingly, 
secretion of MxiCΔCBD was enhanced in a ΔipaB 
background (supplemental Fig. S2). This indicates 
the chaperone-binding domain influences the 
regulation of MxiC secretion rather than the 
intrinsic ability of the protein to become secreted. 
Furthermore, while mxiCΔCBD could not block 
effector secretion, it was able to promote 
translocator secretion (Fig. 3A).  
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Next, we investigated which YopN residues 
contacting the chaperones are conserved in MxiC. 
As the alignment of this area is ambiguous 
(supplemental Fig. S5), we made several single 
and combined charge-swap mutations. mxiCK66E 
was unable to complement ΔmxiC. Paradoxically, 
the mutant protein was detected in culture 
supernatants and, to a lesser degree, in the 
supernatants after CR induction, but only low 
levels were detected in whole culture lysates (Fig. 
3C). mxiC(D46K,D49K) had a wild-type like 
phenotype, except for some premature MxiC 
secretion. mxiC(D46K,D49K,K66E) leaked MxiC 
at high levels and was unable to prevent effector 
secretion (data not shown). A similar phenotype 
was observed in mxiCK68E (Fig. 3). Furthermore, 
mxiCK68E and mxiCK66E, but not mxiCΔCBD, 
displayed reduced induction of translocator 
secretion, suggesting the effect of the point 
mutations on translocator secretion is indirect. 
Therefore, the putative chaperone-binding domain 
is required for regulating MxiC secretion and for 
preventing effector secretion. 
MxiC lacking its secretion signal is not 
secreted and also unable to prevent effector 
secretion (23). In a mxiHK69A mutant where 
MxiC is not secreted, effectors are also not 
released (12,16). Thus, there is a correlation 
between “secretability” and ability to block 
secretion. We hence tested whether MxiC needs to 
be quantitatively removed from the cytoplasm to 
release the block on effector secretion. We 
compared the levels of several secreted proteins in 
supernatants after induction with CR with levels in 
the corresponding total cultures, i.e. samples 
containing secreted and intracellular proteins. The 
translocators IpaB and IpaC were secreted nearly 
completely, while only 8±6% of MxiC was 
secreted in the same period (supplemental Fig. 
S6). Translocator IpaD and early effector IpgD 
were secreted at intermediate levels of ca. 40% to 
50%. Thus, either only a small proportion of 
intracellular MxiC is involved in blocking 
secretion, and/or its secretion per se is not required 
to release this block.  
Any MxiC chaperone remains unidentified 
As MxiC’s putative CBD is essential for 
regulating the protein’s secretion and as Yersinia 
YopN needs its heterodimeric chaperone 
SycN/YscB for efficient secretion and regulation 
(25,30), we wondered whether a chaperone is 
required for MxiC function. Three chaperones are 
encoded on the pWR100 virulence plasmid of 
Shigella that fall into the same general class as 
SycN and YscB: IpgA, IpgE and Spa15 (31). 
Botteaux et al. (2009) already found lack of any of 
these proteins alone has no effect on MxiC 
secretion or stability. Thus, none of Shigella Class 
I chaperones in works like SycN/YscB. However, 
their mechanism of action could be different and 
thus we generated two double deletions 
(ΔipgEΔspa15 and ΔipgEΔipgA) and a triple 
deletion (ΔipgEΔipgAΔspa15). However, even the 
deletion of multiple chaperones had no effect on 
MxiC (supplemental Fig. S7). This suggests that 
none of these chaperones influences MxiC 
function. Therefore, either there are no such 
chaperones binding to the CBD of MxiC or we 
have not identified them because of low sequence 
similarities. However, we think the latter is 
unlikely because MxiC is primarily monomeric in 
cytosol and no known Class 1 chaperone was 
identified, even using mass spectrometry after 
crosslinking (32). 
A hydrophobic patch on the surface of MxiC is 
required for blocking effector secretion 
Deane et al. (2008) noticed conservation 
of a patch of hydrophobic residues on the surface 
of MxiC’s domain 2 (Fig. 1B; L222, M226, G239, 
L242 and L245), suggesting it as a site for protein-
protein interactions. Cherradi et al. (2013) change 
single residues in this patch to alanines (33). MxiC 
is not detectable in mxiCL222A and mxiCL242A, 
while three other mutations (M226A, G239A and 
L245A) do not effect its function. We mutated 
residues L222 and L242 into serines and found 
that neither mxiCL222S and mxiCL242S, nor the 
double mutant mxiC(L222S, L242S) had any effect 
on MxiC stability or function (data not shown). 
As change to a polar side chain may not 
have been enough to disrupt interactions in this 
area, we introduced two charges. The 
mxiC(M226K, L242D) mutant was stably 
expressed (Fig. 4C) and able to induce translocator 
secretion after induction (Fig. 4A). However, 
mxiC(M226K,L242D) was unable to prevent 
effector secretion (Fig. 4A-B). Thus, the 
hydrophobic patch is involved in preventing 
effector secretion. 
Genetic & biophysical study of Shigella T3SS component MxiC 
5		
Mutations in a putative “hinge” area of MxiC 
lead to altered secretion patterns 
The sequence in MxiC helix 9, its putative 
“hinge” region (Fig. 1A), is not conserved. But, it 
contains multiple serines, aspartates, valines and 
threonines that are not classically helix favouring 
(34). Multiple secondary structure prediction 
programmes suggest that even in MxiC, helix 9 
would be broken (supplemental Fig. S8B). We 
generated a model of the “bent” wild-type protein 
using the YopN/TyeA structure (PDB code 1XL3, 
(20)) as template (supplemental Fig. S8A). In 
comparison to the crystal structure, the “bent” 
MxiC model is not only folded at the hinge region, 
but undergoes a slight twisting motion. We then 
made three mutants: one mutant introducing a 
proline (V256P; “bent”) that would likely cause a 
break in helix 9 and thus a conformation similar to 
that of YopN/TyeA, a second mutant introducing 
three glycines (T253G, S254G, D255G; “wobble”) 
in the area to favour switching between both 
putative forms and a third mutant that might 
stabilise a straight helix (I251A, T253A, S254A, 
D255E; “straight”). MxiC I251 is structurally 
equivalent to F268 of YopN, which is sandwiched 
between hydrophobic residues in the core of 
TyeA, thus likely stabilising the bent 
conformation.  
All mutant proteins were expressed at 
wild-type levels or better (Fig. 5C). The triple-
glycine mutant mxiC(T253G,S254G,D255G) 
behaved like ΔmxiC. MxiC was not secreted 
efficiently, translocator secretion was reduced (43 
± 23% of the complemented strain) and effector 
proteins were leaked. In the “straight” mutant 
mxiC(I251A,T253A,S254A,D255E), induced 
secretion of both IpaB and IpaC was reduced, 
while that of IpaD was as efficient as in the 
complemented strain, or even increased (Fig. 5D). 
This mutant did not affect secretion of MxiC or 
effector proteins. The “bent” mutant mxiCV256P 
leaked high levels of a low molecular weight 
protein. We identified this band by mass 
spectrometry using a sample equivalent to the “- 
CR” sample in Fig. 5A. The top T3S-related 
protein identified was effector IpgB1 (6% of the 
total protein content). The similarly-sized 
effector/anti-activator OspD1 was not detected in 
this band. The equivalent band from a ΔmxiC “+ 
CR” sample was analysed in parallel: again, IpgB1 
was the top T3S-related hit (32). The mxiCV256P 
mutant also leaked MxiC at wild-type levels and 
other effector proteins, although less than ΔmxiC. 
Its own inducible secretion was reduced and that 
of all translocators slightly affected (Fig. 5D). 
These results suggest that a “straightened” MxiC 
favours the earliest step in the induction hierarchy, 
i.e. IpaD secretion, whilst a “bent” MxiC can not 
prevent or favours, independently of its own 
secretion, the final one, i.e. effector release. In the 
wobbly mutant, three residues are altered that are 
initially identical to those changed in the straight 
one but its phenotype is opposite, i.e. more like the 
bent one. This indicates that it is not the chemical 
nature of the amino acids in this surface patch that 
leads to these phenotypes, but rather the stability 
of the secondary structure they form. 
MxiC is not in its “straight” conformation in 
solution 
The secretion patterns observed in the 
helix 9 mutants suggested movement in this area 
of MxiC is required for its function. We decided to 
examine the molecular conformation(s) of MxiC 
using double electron-electron resonance (DEER), 
also known as pulsed electron double resonance 
(PELDOR). This an increasingly popular electron 
paramagnetic resonance (EPR) technique used to 
measure distances between paramagnetic spin 
labels on a nanometre-scale (reviewed in (52)). 
Based on the MxiC structure (chain A of 
PDB entry 2VJ4; (21)) and the “bent” model 
(supplemental Fig. S8A), we chose residues A247 
and S290 to introduce paramagnetic centres into 
the molecule as the distance between these 
residues was predicted to be in the measurable 
range for both forms and the difference in distance 
between both forms was predicted as significant 
enough to be detectable (supplemental Fig. S9). 
To covalently couple the paramagnetic nitroxide 
label MTSL to these residues, A247 and S290 
were mutated into cysteines. At the same time, the 
two endogenous cysteines C184 and C233 were 
mutated into alanine and serine, respectively, to 
finally generate a quadruple mutant 
mxiC(C184A,C233S,A247C,S290C) or mxiC(Cys). 
Alternative, complementary mutant MxiCs, with 
cysteines for labelling inserted at two sets of 
different but equally suitable locations, could not 
be purified in sufficient amounts (not shown). 
mxiC(Cys) behaved like the complemented 
strain in a CR secretion assay (supplemental Fig. 
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S10). A His-tagged version of the cysteine mutant 
(His-MxiC(Cys)) was soluble when expressed in 
E. coli (supplemental Fig. S11A). We also 
combined the quadruple cysteine mutant with the 
previously generated “bent” (mxiCV256P) and 
“straight” (mxiC(I251A,T253A,S254A,D255E)) 
mutants. However, neither His-MxiC(bent,Cys) 
nor His-MxiC(straight,Cys) were solubly 
expressed in E. coli (not shown). Thus, we could 
only analyse the “wild-type” His-MxiC(Cys).  
MTSL was covalently coupled to His-
MxiC(Cys) at residues 247 and 290. The protein 
was concentrated and mixed with deuterated 
glycerol for EPR/DEER experiments (for details 
see Experimental Procedures). First, the labelling 
efficiency was assessed using continuous wave 
room temperature EPR on a 35 µM sample (Fig. 
6A). Using a previously obtained standard curve, 
the spin concentration was calculated to be 66 µM. 
The amount of residual unbound label was 
calculated to < 1%, thus a spin labelling efficiency 
of close to 100% could be extracted. The spectrum 
also indicated the protein was folded: because of 
increased mobility in a disordered structure, an 
unfolded protein would result in a spectrum 
similar to that of the free label. 
We subsequently performed a DEER 
experiment to determine the distance distribution 
of the paramagnetic labels on C247 and C290. We 
obtained a distance distribution between 1.5 nm to 
3 nm with two prominent peaks at 2 nm and 2.4 
nm (Fig. 6B-C). Reliability of the two peaks 
comes from the high signal-to-noise F(t) trace. We 
simulated the expected distance distribution for the 
“bent” MxiC model (Fig. 6C) and the MxiC 
structure (PDB code 2VJ4, chain A; Fig. 6B) using 
MMM (35) and found the experimental data 
obtained for labelled His-MxiC(Cys) fit neither 
simulation well (Fig. 6). The major distance peak 
for the straight MxiC structure was around 3 nm 
while in the “bent” MxiC model, the major 
expected distance is at ~ 1 nm. As the distance 
simulations depend on the orientation of the side-
chains to calculate the probabilities of the label 
rotamers, we simulated the expected form factors 
and distances for all seven individual chains in the 
three MxiC crystal structures (PDB codes 2VIX, 
2VJ4 and 2VJ5; (21), supplemental Fig. S12). 
While the modelled form factors all differ in their 
overall shapes, they all show distances in the 1.5 
nm to 3 nm range, in line with the experimental 
set-up. However, the simulated peak at 3 nm was 
not as prominent in the experimental data. We thus 
conclude that the experimental data is consistent 
neither with the structures, nor with the bent 
model. When modelling the possible observable 
distances in the structure and the “bent” model 
using the “all rotamers” function in MMM (35), 
which neglects side-chain atoms, labelling of the 
chosen sites in both conformations can achieve a 
distribution close to the experimentally observed 
distribution (data not shown). Thus, the 
conformation(s) of purified MxiC in solution is 
consistent with both bent and straight forms. 
IpaD interacts with MxiC in solution without 
altering its conformation 
As EPR only detects signals from 
paramagnetic centres, one can add potential 
binding partners to the sample without affecting 
the signal as long as they are diamagnetic. To 
determine whether other T3S related proteins 
influence MxiC’s conformation, we mixed 
labelled His-MxiC(Cys) with a ten-fold molar 
excess of the proposed interaction partner IpaD 
(15) or of Spa15 (supplemental Fig. S11B), a 
protein that is not known to interact with MxiC 
(23). Spa15 addition did not change the continuous 
wave EPR spectrum (Fig. 7A), indicating Spa15 
does not influence the rotational freedom  of the 
labels in MxiC. Consistently, the DEER form 
factor and resulting distance distribution were also 
unchanged (not shown). Thus, Spa15 does not 
affect MxiC’s conformation in vitro. 
In contrast, addition of a 10-fold molar 
excess of purified His-IpaD (supplemental Fig. 
S11C) changed the continuous wave (cw) 
spectrum obtained (Fig. 7C), indicating the 
conformational freedom of the spin-labelled side 
chains has been affected by IpaD-MxiC complex 
formation, either due to direct interaction with 
IpaD residues or to subsequent conformational 
changes in MxiC. To confirm IpaD was 
responsible for signal modification, we mixed 
MxiC with different concentrations of IpaD (Fig. 
8D). We found that the larger the stoichiometric 
fold of IpaD vs MxiC, the bigger was the spectral 
change detected. This shows the signal 
modification is specific to IpaD addition and that, 
in the concentration range used, we can modify the 
ratio of MxiC-IpaD complex vs MxiC alone in the 
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equilibrium ensemble. We also diluted the 10:1 
IpaD-MxiC mix 1:4 (Fig. 7E). This confirmed that 
in preventing the interaction between MxiC and 
IpaD by dilution, the MxiC alone signal is 
recovered, meaning the interaction is reversible.  
Given the evidence that MxiC family 
proteins can interact directly with translocator 
chaperones (27,36-38), we also purified the IpgC 
dimer and an IpaC-IpgC 1:1 heterocomplex ((39); 
supplemental Fig. S11D). Neither of these, added 
at 10-fold molar excesses, interacted with MxiC, 
alone (Fig. 7B) or when added in the presence of a 
10-fold molar excess of IpaD (Fig. 7C). Taken 
together, these data indicate that in solution only 
IpaD displays an affinity for MxiC. However, we 
found no evidence of a distance change between 
the two spin labelled side chains by DEER upon 
addition of any protein partners (data not shown). 
mxiC mutants unable to prevent effector 
secretion are affected differentially by needle 
mutant mxiHK69A, which is unable to release 
MxiC and hence effectors 
To dissect at which point they are deregulated, 
we wanted to understand whether our mxiC 
mutants that leak effectors do so because MxiC’s 
function(s) in blocking effector secretion is 
compromised or because they can not retain MxiC 
intracellularly. We examined this by combining 
them with a mutation that prevents MxiC 
secretion, mxiHK69A. 
A mxiHK69A mutant in the needle protein 
does not secrete effector proteins (16) or MxiC 
secretion (12). However, a mxiHK69A mutant 
lacking MxiC (ΔmxiHΔmxiC/mxiHK69A) can 
secrete effectors (12). Thus, mxiHK69A does not 
physically block effector secretion, but it is unable 
to release MxiC’s block of effector secretion.  
When combining our mxiC mutants with 
mxiHK69A, MxiC mutants that cannot prevent 
secretion because the mutation(s) is affecting 
function should continue to leak effectors even if 
MxiC is retained inside bacteria. For instance, the 
hydrophobic core mxiCF206S mutant (Fig. 1) 
analysed by Cherradi et al. (2013) is not secreted 
in a mxiHK69A background, but still unable to 
block effector secretion. This indicates it has a 
severe defect in its inhibitory function that is 
independent of MxiC secretion (33). On the other 
hand, mutants where MxiC is functional but is 
secreted prematurely should prevent effector 
secretion when MxiC is forced to remain 
intracellular. To test this, we generated mxiH and 
mxiHK69A plasmids compatible with our mxiC 
mutant ones, which were then co-transformed into 
ΔmxiCΔmxiH (see Experimental Procedures). We 
focused solely on MxiC mutants displaying 
premature secretion of effectors and MxiC 
leakage. For completeness, we included also 
mxiC(E201K,E276K,E293), which carries 
mutations in a negatively charged surface patch 
(Fig. 1A), secretes translocators and MxiC 
prematurely and is defective in IpaD secretion 
upon activation (15).  
We were unable to detect leakage from 
ΔmxiCΔmxiH/mxiCmxiH (not shown) and its 
inducible secretion was also slightly reduced 
compared to wild-type but of similar level to that 
of ΔmxiCΔmxiH/mxiCmxiHK69A (Fig. 8, top 
panels). Indeed, slightly fewer functionally mature 
T3SSs are assembled in ΔmxiH/mxiHK69A 
relative to wild-type (16). However, as expected, 
ΔmxiCΔmxiH/mxiCmxiHK69A could not leak or 
induce secretion of the effectors IpaA or IpgD, nor 
of MxiC (Fig. 8, bottom panels), respectively. Yet, 
it secreted slightly reduced amounts of the 
translocators inducibly, as previously observed 
(16). In ΔmxiCΔmxiH/mxiHK69A, IpaA and IpgD 
leakage was restored and their secretion was also 
partially inducible (Fig. 8, bottom panel). We then 
examined how each mxiC mutant behaved in an 
mxiHK69A background. We focused on leakage in 
the absence of induction since activation of MxiC 
secretion is blocked in a mxiHK69A background 
but effector secretion might be allowed by a 
functionally defective MxiC. 
Only mxiCK68E was unable to leak or 
induce effector secretion in the presence of 
mxiHK69A but not of mxiH. This indicates it is the 
only mutant where MxiC would be functional in 
blocking effector secretion, if it were not secreted 
prematurely. All other mutants leak effectors 
similarly whether mxiH or mxiHK69A is present, 
indicating that in these mutants MxiC’s function(s) 
in blocking effector secretion are affected,  either 
directly as in mxiC(M226K,L242D) or indirectly, 
via premature secretion of translocators as in 
mxiC(E201K,E276K, E293). 
Genetic & biophysical study of Shigella T3SS component MxiC 
8		
DISCUSSION 
Classes of mxiC mutants 
Our mutants can be organised into classes 
according to their phenotypes (Table 1). However, 
residues mutated in the different classes do not 
obviously cluster in specific regions of the 
molecule (Fig. 1). Moreover, none seems affected 
only in a single step, i.e. regulation of translocator, 
MxiC or effector secretion. This indicates the three 
regulatory functions of MxiC are interlinked. 
Therefore, the mutants were classified according 
to where their main initial defect lies, assuming 
the regulatory steps occur in this order. 
Only one mutant showed such severe loss-
of-function as to resemble ΔmxiC: mxiCΔCterm, 
which we therefore placed in Class 0. However, 
unlike mxiCΔCterm, mxiCΔNterm and mxiCΔCBD 
were still largely able to induce translocator –but 
not MxiC– secretion, suggesting they are not full 
loss-of-function mutants (Class 1a). Mutant 
mxiCV256P also could not secrete MxiC well 
inducibly or in a ΔipaB background, suggesting it 
has some defect in MxiC secretion. This mutant 
leaks effectors but as it can still stimulate secretion 
of translocators, it is also not a complete loss-of-
function mutant (Class 1a). Both classes of 
mutants readily by-passed the block on effector 
secretion imposed by mxiHK69A although none 
secreted MxiC efficiently in this background, 
indicating they are unable to establish all or some 
of MxiC’s regulatory functions. 
mxiCK66E and mxiCK68E are 
phenotypically similar in that they secrete MxiC 
prematurely, and hence show reduced translocator 
induction and increased effector leakage. 
However, MxiCK68E is secreted much more 
efficiently than MxiCK66E. Furthermore, amongst 
all mutants, only MxiCK68E does not leak 
effectors in a mxiHK69A background. This 
indicates that the mutations in MxiCK68E and 
MxiCK66E, despite their proximity and chemical 
similarity, lead to different defects. K68E (Class 
1c) primarily deregulates MxiC secretion, leading 
it and effectors to be secreted prematurely. On the 
other hand, in addition to some premature 
secretion, K66E (Class 1b) seems to confer more 
fundamental defect(s) leading to effector leakage. 
Finally, the only defect seen in 
mxiC(M226K,L242D) is effector leakage (Class 
1d). 
Class 2 mutants are primarily, if 
oppositely, affected in translocator release: 
MxiC(E201K,E276K,E293) can not induce IpaD 
secretion but leaks IpaB, IpaC, itself and effectors 
(15), while MxiC (I251A,T253A,S254A, D255E) 
displays increased IpaD secretion and reduced 
IpaB and IpaC secretion.  
 
Properties of MxiC and roles of its termini  
Using the mutant classes, we conclude that 
several physiological features of MxiC are 
regulated: 1) its secretion, since several mutants 
up- or downregulate it; 2) hierarchical secretion of 
translocators and effectors, and even of proteins 
within those two categories; 3) the ability to 
switch from translocator to effector secretion. 
There are also uncharacterised fundamental 
properties of MxiC as indicated by mutations that 
most likely do not affect its overall structure, i.e. 
mxiCΔCterm and mxiCΔNterm, but still lead to full 
or partial null phenotypes, respectively. 
That MxiC’s secretion signal and putative 
CBD are dispensible for stimulation of 
translocator secretion indicate Domains 1-3 alone 
mediate this function. Multiple residues in the C-
terminal helix of MxiC are highly conserved. 
Schubot et al. (2005) suggested that the C-terminal 
helix of Yersinia TyeA (a MxiC domain 3 
homolog which binds the C-terminus of YopN, a 
MxiC domains 1-2 homolog) might localise the 
YopN/TyeA complex to the secretion apparatus. 
Ferracci et al. (2005) found TyeA to be essential 
for YopN to block secretion. In addition, several 
mutants in the hydrophobic core of domain 2 (Fig. 
1) of MxiC are non-functional or at least unable to 
block secretion (33). In contrast, equivalent 
mutations in Yersinia yopN lead to a general block 
of secretion (19,33). However, the yopN mutants 
analysed by Ferracci et al. (2005) were 
overexpressed in comparison to wild-type levels. 
In our hands, overexpression of the non-functional 
hydrophobic core of domain 2 mxiCD225V mutant 
(Fig. 1) also led to a general block of secretion 
(not shown). This suggests MxiC blocks an 
acceptor site on the secretion apparatus and too 
much non-removable protein prevents release of 
this repressor, consequently blocking secretion. In 
support of this, Lee et al (2014) showed Pcr1, the 
Pseudonomas T3SS homologs of Yersinia TyeA, 
interacts with the T3SS inner membrane protein 
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PcrD, known as MxiA in Shigella (40). 
Furthermore, the extreme C-terminus of MxiC is 
required for interaction with the cytoplasmic 
region of MxiA (41), explaining the null 
phenotype of mxiCΔCterm. As mutants in the N-
terminus and CBD are unable to secrete MxiC 
inducibly and an N-terminal His-tag on MxiC led 
to a ΔmxiC phenotype (data not shown), these 
regions may also be involved in binding it to and 
releasing it from that site. 
MxiC differentially affects secretion of IpaD 
and hydrophobic translocators 
Translocator secretion was largely 
unaffected in Class 1a and 1d mutants whilst all 
had clear defects in blocking effector secretion. In 
contrast, mutants from Class 2 modulated 
translocator secretion, but effector secretion was 
affected indirectly (mxiC(E201K,E276K,E293K)) 
or not at all (mxiC(I251A,T253A,S254A, D255E)). 
Thus, the action of MxiC on translocators and 
effectors can be uncoupled. 
MxiC(E201K,E276K,E293K) acts as if it had 
already received the activation signal (15). Thus, 
MxiC’s action on translocators can also be 
uncoupled from the needle-transmitted activation 
signal. In addition, MxiC secretion is not required 
for activating translocator secretion, as a 
mxiHK69A mutant –which does not secrete MxiC– 
and mxiCΔNterm secrete normal levels of 
translocators (12,16). 
Even hydrophilic versus hydrophobic 
translocator secretion can be uncoupled since 
mxiC(E201K,E276K,E293K) leaks IpaB and IpaC 
and is unable to induce IpaD secretion (Roehrich 
et al. 2013). Interestingly, the “straight” mutant 
mxiC(I251A,T253A,S254A,D255E) instead 
displays reduced induction of IpaB and IpaC, 
while IpaD secretion is slightly increased. These 
opposite effects correlate with the mutations being 
on opposite faces of MxiC (Fig. 1, top). These 
faces are also the ones that may undergo a 
conformational change from flat to bent (21). In 
fact, this is the conformational change we tried to 
prevent in mxiC(I251A,T253A,S254A,D255E). 
Furthermore, the predicted “bent” mutant 
(mxiCV256P) and the predicted “straight” mutant 
show opposite phenotypes: while the former leaks 
effectors and is only weakly affected in 
translocator secretion, the latter shows differential 
induction of translocators. Thus, reduced secretion 
of the repressor IpaD could affect secretion of the 
hydrophobic translocators. Alternatively or 
additionally, MxiCV256P was only poorly 
secretable and could be affected in more 
fundamental functions. While we cannot exclude 
that these mutations mainly affect MxiC 
interactions by altering its surface, the type of 
mutations, the fact that the mutations are directly 
adjacent and their opposite phenotypes suggest 
that we have modified MxiC’s ability to undergo 
conformational changes. 
A conformational change in MxiC?  
The negatively charged patch mutated in 
mxiC(E201K,E276K,E293K) lies on the face of the 
molecule that is flat in MxiC, but concave in 
YopN/TyeA and the E.coli homolog SepL (26). 
As the “straight” mutant favoured IpaD secretion, 
a flat negatively charged patch might be required 
for this. Lower levels of IpaB and IpaC secretion 
could then be due to the restricted conformation or 
to the mutations themselves. In other words, IpaB 
and IpaC secretion could require either a bent 
conformation or the area in helix 9 that was 
mutated in mxiC(I251A,T253A,S254A, D255E), or 
both. The latter is supported by the work of 
Archuleta et al. (2014), which indicates that a 
flattened gate-keeper structure has a conserved 
binding site for translocator chaperones, such as 
IpgC in Shigella, at this location (27). In the 
Salmonella SPI-1 system, the MxiC homologue 
InvE interacts with complexes of hydrophobic 
translocators and their chaperone (36). An 
interaction between MxiC or its homologue and 
the class 2 chaperone IpgC or its homologue has 
also been shown in Shigella and Chlamydia 
(33,38). Finally, we identified substoichiometric 
amounts of IpgC and all translocators in our 
interaction partner screen (32). 
MxiC directly interacts with IpaD 
Unfortunately, we were to unable to test 
for any conformational change in MxiC by EPR. 
However, we did detect an interaction between 
MxiC and IpaD via this method. The spectral 
changes observed in the continuous wave EPR 
experiments where MxiC(Cys) and IpaD were 
mixed have two possible explanations: i) the 
increased molecular weight of the complex(es), 
which is reflected in slower overall rotational 
correlation times; ii) a direct interaction between 
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the spin-labelled probes and residues in IpaD. 
While the reason of the spectral effects observed 
cannot be clarified, it corroborates the notion that 
complex formation between MxiC and IpaD 
occurs. From Fig. 7B, assuming the 1:10 
MxiC:IpaD concentration corresponds to the 
maximum amount of complex formation and 
therefore that a 1:5 molar ratio IpaD gives half 
maximum complex concentration, we estimate the 
dissociation constant of the MxiC-IpaD complex is 
~730 µM, i.e. these purified proteins have very 
low affinity. This suggests we have not fully 
reconstituted interactions between these proteins 
in vitro. We may be lacking their “scaffold”. 
Perhaps the MxiAC oligomer, aided by other T3SS 
export apparatus components, stabilises one of 
MxiC’s conformations? 
Based on the crystal structures of IpaD 
(42) and MxiC (21) and the mutations genetically 
affecting the interaction between these proteins 
(ipaDL99P and mxiC(E201K,E276K,E293K); 
(15)), we built a model of the MxiC/IpaD 
interaction: the MxiC and IpaD structures pack 
readily against each other (Fig. 9A), with the 
negatively charged patch of MxiC (E201, E276 
and E293) at their interface, yielding an overall 
elongated form. The interacting surface is 
relatively flat, contains several charged residues 
on the edges and stacked tyrosine residues in the 
centre giving an interface formed by two charge-
complementary surfaces (Fig. 9B). This model is 
consistent with the data of Lee et al. (2014), who 
found that Pseudomonas PcrG, a homolog of the 
N-terminus of IpaD, interacts with Pcr1, a MxiC 
domain 3 homolog (40). Taken together with the 
work of Archuleta et al. (2014) (27), our model 
suggests why MxiC’s N-term and CBD are 
dispensible for stimulating translocator secretion. 
Intramolecular and external signals for MxiC 
secretion  
By analysing the mxiCΔNterm mutation in 
the constitutive secreter background ΔipaB we 
confirmed that this mutant is unsecretable. Similar 
to the N-terminal secretion signal, the putative 
chaperone-binding domain is required for efficient 
MxiC secretion. However, this domain did not 
affect secretability. Thus, MxiC secretion is 
merely deregulated in mxiCΔCBD. Interestingly, 
two different mutations in the CBD of MxiC led to 
increased MxiC leakage: mxiCK68E and 
mxiCK66E. Taken together, these data suggest that 
the putative chaperone-binding domain positively 
regulates MxiC secretion.  
That the chaperone-binding domain is 
irrelevant for MxiC secretion in the ΔipaB 
background is reminiscent of the lack of 
requirement of MxiC for translocator secretion in 
the same background. Similar to the repression of 
translocator secretion (12), an intracellular 
repressor mechanism for MxiC secretion might be 
put into place once the tip is fully assembled: the 
CBD would be involved in counteracting this 
mechanism and mutants mxiCK68E and 
mxiCK66E would then either be better at 
counteracting the mechanism repressing MxiC 
secretion or less sensitive to it. 
The “external” signal for MxiC secretion 
has not yet been identified. However, this signal is 
likely transmitted through the needle as a 
mxiHK69A mutant is unable to release MxiC even 
when secretion is artificially activated by 
additional deletion of ipaB (12). The question of 
how mxiHK69A blocks MxiC secretion remains: 
the mxiHK69A mutant is either unable to transmit 
an external activation signal for MxiC secretion 
generated after the translocators have been 
secreted, or this mutation alters the affinity of the 
secretion apparatus for MxiC (12,32). 
Mutants mxiCK68E and mxiCK66E leaked 
the respective mutant protein and hence probably 
overcome an intracellular repression mechanism 
for MxiC secretion. Similarly, 
mxiC(E201K,E276K,E293K) has gained the ability 
to activate its own secretion (15). However, none 
of these mutants is inducibly secreted in the 
mxiHK69A background. Indeed, we did not 
identify any mutation allowing induction of MxiC 
secretion in the mxiHK69A background. Thus, in 
addition to blocked transmission of Signal 2, the 
secretion apparatus in the mxiHK69A mutant is 
unable to release/recognise MxiC as a secretion 
substrate. 
MxiC secretion per se is not required to 
derepress effector secretion  
In the wild-type, the needle transmits the 
activation signal to MxiC, whose subsequent 
secretion leads to derepression of effector 
secretion. Classe 1a mutants, which only secrete 
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MxiC poorly, but leak effectors, show that effector 
secretion and MxiC secretion can also be 
uncoupled. In other words, MxiC secretion per se 
is not required for allowing effector secretion. Not 
all MxiC homologues are secreted (28). However, 
the gate-keepers must be removed from their 
initial place of action: in the Salmonella SPI-2 
system where the MxiC homologue SsaL is not 
secreted, the protein dissociates from the 
membrane and is degraded once secretion is 
activated (43).  
Further regulatory function(s) for MxiC? 
Mutant mxiCV256P leaked effectors, but 
specifically high levels of IpgB1. IpgB1 is an 
effector protein chaperoned by Spa15 (24,44). The 
specific effect of mxiCV256P on IpgB1 suggests 
that MxiC somehow directly affects secretion of at 
least some effectors. Similarly, E. coli SepL was 
shown to specifically act on the effector Tir. This 
protein-protein interaction was proposed to be 
critical for regulating secretion of the other 
effector proteins (28). Though this does not 
exclude a possible effect of MxiC on effector 
secretion in a more general way, e.g. by 
modulating the affinity or physically blocking an 
acceptor site for effectors in the T3SS, it suggests 
that secretion of specific effectors involves an 
additional regulatory layer. 
Steps in MxiC function 
After T3SS assembly, but prior to 
secretion activation, multiple mechanisms are in 
place that prevent premature secretion of the 
different protein types. Translocator secretion is 
repressed by IpaD, probably via interaction with 
MxiC bound to MxiA. An uncharacterised 
mechanism prevents MxiC secretion, while this 
protein itself prevents effector secretion. When the 
needle tip comes in contact with a host cell, an 
activation signal (“Signal 1”) is transmitted to the 
cytoplasm, most likely through the needle. 
The mechanism preventing premature 
translocator secretion is counteracted by MxiC. 
Secretion of IpaD requires the negatively charged 
patch and probably a flat conformation of the 
molecule. Removal of IpaD may initiate a 
conformational change in MxiC, which bends to 
release the IpgC chaperone and its bound 
translocators allowing these to become secreted in 
turn. IpaB and secreted IpaC form a pore, 
connected to IpaD at the needle tip and also 
inserted in the host cell membrane, which 
transmits “Signal 2” to the cytoplasm. Reception 
of this signal may allow finalisation of a 
conformational change in MxiC that releases it for 
secretion. Then, early effectors are secreted. 
Moreover, as both negative regulators are now 
removed, the secretion rate is enhanced (40), 
possibly through alteration of its mode (41). 
By using structure- and sequence based 
mutagenesis of mxiC, we dissected at which stages 
of the regulatory cascade MxiC acts with which 
function and which steps can be uncoupled. This 
also allowed us to determine how the different 
steps are connected. Finally, we provide the first 
evidence that directionally defined conformational 
change in MxiC is involved in controlling the 
secretion hierarchy. The conservation of the 
components involved indicates the importance of 
this regulatory pathway to T3SS-carrying bacterial 
pathogens of animals. 
EXPERIMENTAL PROCEDURES 
Bacterial strains, plasmids and primers 
Supplemental Tables S1 and S2 list the strains and 
plasmids used. S. flexneri strains were grown in 
Trypticase Soy Broth (Becton Dickinson) at 37°C 
with appropriate antibiotics at following final 
concentrations: ampicillin 100 µg ml-1, 
kanamycin 50 µg ml-1, tetracycline 5 µg ml-1, 
chloramphenicol 10 µg ml-1. IPTG was used at the 
final concentrations indicated in the Fig. Legends. 
Supplemental Table S3 lists the primers used. 
Construction of plasmids 
Plasmids were generated as described below and 
verified by sequencing. 
pIMA221 (pWSK29*mxiC) was generated by 
amplifying mxiC from the Shigella virulence 
plasmid pWR100 using primers mxiC_SacI and 
mxiC_BamHI. The purified PCR product was 
digested with SacI and BamHI and cloned into 
pWSK29* (modified pWSK29 (45) lacking the T7 
promoter, a gift from Andrew Davidson 
(University of Bristol) digested with the same 
enzymes. 
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Terminal deletions and mutations. To express 
the terminal mxiC deletions, mxiC was amplified 
from pIMA221 using primers mxiC_SacI_del30 
and mxiC_BamHI for mxiCΔNterm, primers 
mxiC_SacI and mxiC_341 for mxiC(1-341). The 
resulting PCR products were digested with SacI 
and BamHI. Fragments mxiCΔNterm and mxiC(1-
341) were cloned into pACT3 digested with 
SacI/BamHI yielding pDR60 and pDR73, 
respectively. 
Chaperone binding domain mutants. pDR80 
contains mxiCΔCBD, an internal deletion mutant 
that was created by two step PCR and lacks 
residues 32 to 72. The mxiC gene was amplified 
from pIMA208 using primer pairs 
mxiC_SacI/mxiC_D32-72_R and mxiC_D32-
72_F/mxiC_BamHI. The obtained PCR fragments 
were used as template for the second PCR step 
using primers mxiC_SacI and mxiC_BamHI. The 
PCR product was purified, digested with 
SacI/BamHI and ligated into pACT3 digested with 
the same enzymes. 
 
Mutant mxiCK66E was generated by two-step 
PCR. First, mxiC was amplified from pIMA208 
using primers mxiC_SacI and mxiC_K66E_R and 
or mxiC_K66E_F and mxiC_BamHI, respectively. 
These fragments were combined and reamplified 
using mxiC_SacI and mxiC_BamHI. The PCR 
products were purified, digested with SacI and 
BamHI and cloned into pACT3 digested with the 
same enzymes yielding pDR96. pDR100 contains 
mxiCK68E cloned via SacI/BamHI, equivalent to 
amplification of mutant mxiC using primers 
mxiC_SacI and mxiC_BamHI. This mutant was 
obtained by chance and retained as the mutation 
was in a relevant area of the molecule. 
Hydrophobic patch mutant. Double mutant 
mxiC(M226K,L242D) was generated by two-step 
PCR. First, pIMA212 was used as template for 
reactions with primer pairs 
mxiC_SacI/mxiC_M226K_R and 
mxiC_L242D_F/mxiC_BamHI. The obtained 
fragments were combined and reamplified using 
primers mxiC_SacI and mxiC_BamHI. The 
product was purified, digested with SacI and 
BamHI and cloned into pACT3 digested with the 
same enzymes, yielding pDR72. 
Hinge region mutants. Mutants in helix 9 were 
generated by two-step PCR: first, mxiC was 
amplified from pIMA208 using primer pairs 
mxiC_SacI/mxiC_V256P_R, 
mxiC_V256P_F/mxiC_BamHI, 
mxiC_SacI/mxiC_wobble_R, 
mxiC_wobble_F/mxiC_BamHI, 
mxiC_SacI/mxiC_straight_R2, 
mxiC_straight_F2/mxiC_BamHI. The obtained 
PCR fragments were used as template for the 
second PCR using primers mxiC_SacI and 
mxiC_BamHI. The products were purified and 
digested with SacI/BamHI before ligation into 
pACT3 digested with the same enzymes. The 
resulting plasmids were named pDR91 
(pACT3mxiCV256P), pDR92 
(pACT3mxiC(T253G,S254G,D255G)) and 
pDR93(pACT3mxiC(I251A,T253A,S254A,D255
E)), respectively. The background quadruple 
cysteine mutant gene mxiC(Cys) (Cys184Ala 
(TGT to GCA), Cys233Ser (TGT to TCT), 
Ala247Cys (GCA to TGT), Ser290Cys (AGT to 
TGT)) required for EPR experiments was 
synthesised by MWG Eurofins and supplied as 
pEXA-mxiC_EPR2. For pDR104 
(pET28bmxiC(Cys)), mxiC(Cys) was amplified 
from the pEX-A-mxiC_EPR2 using primers 
mxiC_NdeI_F/mxiC_EcoRI_R. The PCR product 
was purified and digested with NdeI/EcoRI before 
cloning into pET28b (Novagen). 
Chaperone mutants 
Deletions of the chaperone genes were performed 
using the method of Datsenko and Wanner (46). A 
kanamycin cassette was amplified from pKD4 
using primers ipgA_KO_kanF/ipgA_KO_kanR, 
ipgE_KO_kanF/ipgE_KO_kanR and 
spa15_KO_kanF/spa15_KO_kanR, respectively. 
The primers contained ca. 50 bp upstream and 
downstream of the respective chaperone gene to 
allow for recombination by the λ Red 
recombinase. These fragments were introduced 
into Shigella wild-type yielding ΔipgA, ΔipgE and 
Δspa15, respectively. For ΔipgE Δspa15 
(abbreviation of ΔipgE::FRT Δspa15::kan) and 
ΔipgE ΔipgA (abbreviation of ΔipgE::FRT 
ΔipgA::kan), the kanamycin cassette was removed 
in ΔipgE by FLP mediated recombination using 
the introduced FRT sites yielding ΔipgE::FRT. 
The same fragments used for the deletion of spa15 
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and ipgA in the wild-type background were now 
used for λ Red recombination in ΔipgE::FRT. This 
step was of low efficiency as the recombination 
preferentially occurred at the FRT scar at the 
ΔipgE site and not up- and downstream of spa15 
and ipgA, respectively. Colonies were prescreened 
by colony PCR using primers annealing ca. 200 bp 
to 300 bp upstream and downstream of the original 
chaperone gene, seeking to obtain a PCR fragment 
with a size compatible with the insertion of the 
kanamycin cassette versus the chaperone gene. 
ΔipgE ΔipgA Δspa15 (abbreviation of 
ΔipgE::FRT ΔipgA::FRT Δspa15::kan) was 
generated by removing the kanamycin cassette in 
ΔipgE ΔipgA by FLP recombination yielding 
ΔipgE::FRT ΔipgA::FRT and subsequent λ Red 
recombination using the ipgA::kan PCR fragment. 
Again, this step was of low efficiency as now two 
FRT sites were available on the virulence plasmid 
and colonies were prescreened by colony PCR as 
described for the double knockouts. All insertions 
and cassette removals were verified by 
sequencing. 	
Combination of mxiC and mxiH mutants 
Some of the mxiC plasmids detailed above were 
then combined with plasmids carrying 
mxiHK69A, or wild-type mxiH as control in 
ΔmxiCΔmxiH (12). mxiH and mxiHK69A were 
amplified from corresponding templates (16) using 
primers mxiH_NdeI_For and mxiH_PstI_Rev, and 
cloned into a previously described pUC18 vector, 
modified to carry a constitutive lac operator (14). 
This was done so when both pACT3 containing 
mxiC and pUC18 containing mxiH were 
transformed into ΔmxiCΔmxiH bacteria, mxiH 
expression would not be inhibited by LacI, 
encoded on pACT3, binding to the lac operator of 
pUC18. The corresponding bacteria had normal 
expression of mxiH and mxiC in the presence of 
25 µM IPTG except ΔmxiCΔmxiH/mxiCΔNterm 
mxiH wild-type or K69A when 100 µM IPTG was 
used to ensure sufficient expression of this mxiC 
mutant. 
Type III secretion functional assays 
Analysis of protein expression levels. Whole 
cultures of S. flexneri in late exponential phase 
(OD600 ca. 1) were mixed with 4x Laemmli sample 
buffer (“whole culture lysates”). Samples from 
equivalent cell numbers (ca. 3 x 106 cfu) were 
separated by 10% SDS-PAGE and immunoblotted. 
Analysis of leakage. S. flexneri strains grown to 
OD600 ca. 1 were collected by centrifugation at 
15900 g for 10 min at 4oC. The supernatants were 
mixed with 4x Laemmli sample buffer, normalised 
for equivalent cell numbers, separated on 10% 
SDS-PAGE and visualised by silver staining or 
immunoblotting. On silver stained SDS-PAGE, 
labels indicate the position of proteins as 
determined by mass spectrometry or from deletion 
strains.  
Analysis of inducible protein secretion. Congo 
red (CR), a small amphipatic dye molecule, is an 
artificial inducer of T3S. Its addition to a Shigella 
culture leads to a burst of Ipa protein secretion 
called “induction” (47,48). S. flexneri at OD600 ca. 
1 were collected by centrifugation at 4500 g and 
resuspended in PBS to an OD600 of 5, i.e. ca. 1.5 x 
109 cfu ml-1. For each strain, two reaction tubes 
were prepared with 500 µl bacterial suspension. 
To one of the tubes, CR (Serva) was added to a 
final concentration of 200 µg ml-1. After 
incubation at 37oC for 15 min, samples were 
centrifuged at 15900 g for 10 min at 4°C. 20 µl of 
the supernatants denatured in Laemmli sample 
buffer were subjected to 10% SDS-PAGE and 
visualised by silver staining or immunoblotting. 
Western blotting 
Proteins were transferred onto Immobilon FL 
(Millipore) membrane using a semi-dry method. 
Primary antibodies used were: anti-IpaA mouse 
monoclonal, gift from Kirsten Niebuhr (3); anti-
IpaB mouse monoclonal, named H16, gift from 
Armelle Phalipon (49); anti-IpaC mouse 
monoclonal, mixture of J22 and K24, gift from 
Armelle Phalipon (50) anti-IpaD rabbit polyclonal, 
gift from Claude Parsot (51) or as described in 
Cheung et al. (2015); anti-IpgD mouse 
monoclonal, gift from Kirsten Niebuhr (3); anti-
MxiC rabbit polyclonal, raised against a fragment 
of MxiC containing residues 74 to 355 and an N-
terminal His-tag (12). Near-infrared fluorescent 
secondary antibodies (rabbit IgG raised in goat 
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and coupled to Alexa680, Invitrogen; mouse IgG 
raised in goat and coupled to DyLight800, Pierce) 
were visualised and quantified on a Li-Cor 
Odyssey imaging system. 
Calculation of the secreted percentage of a 
protein 
Wild-type Shigella were grown to OD600 ca.1 and 
resuspended in PBS to an OD600 of 15. The 
suspension was brought to 37°C in a waterbath 
before CR was added at a final concentration of 
200 µg ml-1 and the cultures were incubated for 8 
min. For secreted proteins, samples were 
centrifuged at 15 000 g for 10 min at 4°C and 
supernatants were denatured in Laemmli sample 
buffer. For whole cultures, the bacterial 
suspension was directly denatured in sample 
buffer. To calculate the secreted percentage of 
each protein, we compared protein amounts in 
supernatants and whole cultures by Western 
blotting. Undiluted and 1:4 diluted supernatant 
was compared to a dilution series of the whole 
cultures. Near-infrared fluorescent secondary 
antibodies were quantified on a Li-Cor Odyssey 
imaging system. A linear fit of the dilution series 
allowed us to determine the concentration of 
protein in the supernatant in comparison to the 
whole culture. 
EPR spectroscopy 
Modelling of the bent MxiC structure. To create 
a model of the putative bent form of MxiC, its 
straight crystal structure (PDB code 2VJ4, (21)) 
and the structure of YopN/TyeA (PDB code 
1XL3, Schubot et al. (2005)) were used. In a first 
step, MxiC was superimposed on YopN and TyeA 
independently. The majority of the first two X-
bundle domains of MxiC (residues 64 to 253) were 
matched to YopN and the C-terminal domain of 
MxiC (residues 254 to 355) was matched to TyeA. 
Then the respective MxiC domains were taken and 
the link between them (residues 250 to 260) was 
rebuilt manually, guided by the conformation of 
the equivalent region in YopN. This model was 
soaked in a 1 nm layer of water molecules and 
relaxed with 5000 steps of energy minimisation 
under the Cvff forcefield. Insight II 2005 was used 
for the modelling and Discover 2.98 (both 
Accelrys Inc.) for the energy calculations. 
Modelling of interspin distances. The spin label 
MTSL ((1-oxyl-2,2,5,5-tetramethylpyrroline-3-
methyl)methanethiosulfonate; Berliner et al. 
(1982)) is relatively long and flexible: the linker to 
the protein backbone contains five dihedral angles. 
Thus, depending on the rotameric state of each 
spin label in a protein, the interspin distance can 
vary significantly. When bound to a protein, the 
spin label’s rotamers have different energies due 
to their interactions with the neighbouring side-
chains of the protein. The most favourable 
rotamers and thus the most likely distance 
distribution were calculated using MMM version 
2013, a Matlab package ((35), 
http://www.epr.ethz.ch/software/index).  We used 
eight different MxiC structures to calculate the 
interspin distance distribution: the “bent” MxiC 
model and all seven MxiC crystal structures from 
Deane et al. (2008) (PDB codes 2VIX, 2VJ4 and 
2VJ5) were extracted so that only a single 
polypeptide chain was present in each PDB-file. 
This was necessary as the labelled residues (247 
and 290) are in close proximity to the other 
polypeptide chains in the original PDB files. The 
neighbouring chains thus also influence the 
rotamer modelling, however, MxiC is most likely 
monomeric in solution (21) thus these additional 
interactions are not meaningful and were 
excluded.  
Protein purification. Each protein was purified 
firstly by Nickel affinity chromatography and then 
by size-exclusion chromatography. The protocols 
for these purifications were based on articles 
herewith: Spa15 (53), IpgC/IpaC (39), 
MxiC(C184A/C233S/S243C/S290C) (21). For 
IpaD, a C322S mutant was used to avoid the 
requirement for DTT addition during the 
purification (54). For this, His6-IpaD15-332 C322S was 
amplified from pUC18 ipaDC322S (14) using 
primers ipaD15_NdeI_For and ipaD_BamHI_Rev 
(supplemental Table S3), and cloned into pET15b 
(Novagen) via NdeI/BamHI. The changes to the 
protocol for each protein are detailed in 
supplemental Table S4. 
 
All protein concentrations, measured with a 
Nanodrop Lite Spectrophotometer (Thermo 
Scientific), were adjusted using molecular weight, 
extinction coefficient (as obtained from the 
Expasy server) of the protein and considering also 
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the path length. Prior to each protein purification, 
the appropriate bacterial strain was streaked out on 
an Lysogeny Broth (LB) agar plate containing the 
appropriate antibiotics and grown overnight at 37 
°C. The next day small LB cultures were made 
overnight. In the morning, cultures were made 
with overnight cultures (supplemental Table S4). 
Bacteria were grown to an OD600 of ca. 0.6 before 
cooling to 20 °C and induction with a final 
concentration of 1 mM IPTG. Cultures were then 
left shaking at 20 °C overnight. 
Cells were harvested by centrifugation (5000 g 15 
minutes), washed in 10 ml PBS (3500 g rpm 15 
min) and resuspended ca. 30 ml Binding buffer 
with protease inhibitors (Complete EDTA-free, 
Roche). Bacteria were lysed by sonication (Sonics 
Vibra cell™) amplitude 60 %, pulse 1 sec on 1 sec 
off, Time 30 sec and variable cycle numbers 
(supplemental Table S4). 
Lysates were clarified by centrifugation for 30 min 
at 20000 g at 4 °C. Supernatants were filtered 
through a 0.45 µm and then 0.22 µm syringe filter 
(Sartorius) and applied to a 5 ml HisTrap FF 
column (GE Healthcare) equilibrated in binding 
buffer (supplemental Table S4) using a peristaltic 
pump (GE Healthcare). The entire supernatant was 
passed over the column three times at 2.5-5 
ml/minute at 4 °C. The column was then 
connected to an ÄKTA (GE Healthcare) and 
washed with 10-15 column volumes of Binding 
buffer, followed by elution buffer (supplemental 
Table S4). Elution of bound proteins was carried 
out in the presence of protease inhibitors, with an 
imidazole gradient from 20 mM to 1 M (Elution 
buffer; supplemental Table S4) to 3 ml/min for 25 
min. 5 ml fractions were collected. Peak fractions 
potentially containing proteins of interest had their 
concentration determined at A280 and were 
examined using Coomassie-stained SDS-PA gels. 
The appropriate fractions were pooled and 
concentrated using Amicon Ultra spin 
concentrator (Molecular cut off, Millipore; 
supplemental Table S4). 
These concentrated fractions were run on a 
Superdex75 10/30 size exclusion chromatography 
column (GE Healthcare) equilibrated in 20 mM 
TrisHCl pH 7.5, 100 mM NaCl, 100-250 µl 
samples were applied and the column run at 0.5 
ml/min collecting 1 ml fractions. Location and 
purity of proteins of interest was verified by 
Coomassie-stained SDS-PAGE. After the final gel 
filtration step, all samples were concentrated as 
above (supplemental Table S4) and flash frozen in 
aliquots in liquid nitrogen and stored at -80 °C 
until use. 
MxiC labelling. 1 mM freshly made DTT 
(dithiothreitol; Sigma) was added to 
MxiC(C184A/C233S/A247C/S290C) to reduce 
the SH of the cysteines before concentration and 
application on the gel filtration column. The 
fractions containing His-
MxiC(C184A/C233S/A247C/S290C) (ca. 2.12 
mg/ml) were pooled and the spin label MTSL (1-
oxyl-2,2,5,5-tetramethylpyrroline-3-methyl) 
methanethiosulfonate; Berliner et al., 1982; 
Toronto Research Chemicals, Toronto, Canada), 
was added at two-fold molar excess (ca. 121 µM). 
This means one molecule of MTSL was added per 
cysteine in the sample. After incubation for 
overnight at 4°C in the dark, the sample was 
concentrated to ca. 1.842 mM (~70 mg/ml) as 
determined by the A280 using Amicon Ultra-4 spin 
concentrators (10 kDa molecular weight cut off, 
Millipore). 
Determination of the spin concentration and 
labelling efficiency using continuous wave EPR. 
To determine the labelling efficiency of His-
MxiC(Cys) with MTSL, continuous wave EPR 
spectra were detected at room temperature on a 
E500 Elexsys Bruker spectrometer equipped with 
a super high Q cavity. The samples were thawed 
on ice and 20 µl were transferred into a 1.5 mm 
outer diameter glass capillary. A 14 mT field 
sweep was performed, with 0.15 mT modulation 
amplitude, 7.96 mW incident microwave power, 
ca. 9.38 GHz frequency. As the measured signal is 
the first derivative, the resulting curve has to be 
integrated to obtain the absorbance spectrum. 
Double integration yields the spin concentration as 
horizontal asymptote. The area under the 
absorbance spectrum is proportional to the spin 
concentration. The correlation factor was 
experimentally determined with a solution of 
known concentration of tempol in water. 
Distance measurement using DEER. In this 
work the Q-band DEER experiments were 
performed as described in Polyhach et al. (2012). 
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By using deuterated cryoprotectants, the relaxation 
time can be increased thus increasing range of 
distance measurement and sensitivity. As protein 
samples are analysed at 50 K after flash-freezing 
in liquid nitrogen, the equilibrium population is 
observed, thus yielding a distance distribution 
rather than a single distance. For DEER, the 
sample was thawed on ice, 50 µl were transferred 
into a quartz tube (3mm outer diameter, Aachener 
Quarz-Glas Technologie Heinrich) and flash 
frozen in liquid nitrogen. Optimisation and 
evaluation of Q-band DEER experiments is 
described in Bordignon and Polyhach (2013). Data 
was acquired for 4 h to 12 h. Normalised 
experimental data (V(t)=V(0)) are background 
corrected to obtain the DEER form factor 
(F(t)=F(0)) by division by the background function 
(which is mainly due to intermolecular 
interactions). The form factor oscillates around a 
horizontal line at (1 - Δ) (Δ is the modulation 
depth) after background correction. The distance 
distribution is extracted from the form factor using 
DeerAnalysis2013 ((55), 
http://www.epr.ethz.ch/software/index). 
Analysis of interactions between MxiC and 
other proteins using EPR. To analyse the 
interaction between MxiC and other proteins, we 
performed continuous wave X-band EPR 
spectroscopy at room temperature to detect 
eventual changes in the dynamic properties of the 
two spin labels on MxiC upon complex formation. 
Each EPR sample was prepared in gel filtration 
buffer (20 mM Tris-HCl pH 7.5, 100 mM NaCl), 
and contained a final concentration of ca. 75 µM 
of MxiC and 10 fold more of the other proteins 
(ca. 750 µM). 
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TABLE 1. Phenotypic overview of mutants 
apoorly detected in whole cell lysate; b IpaB/C increased; c not IpaD; d IpaC/B reduced, IpaD slightly increased; e IpgB1 increased 
Mutant Design group 
MxiC Translocators Effectors in mxiHK69A background Phenotypic class 
Main secretion 
defect 
leaked induced in ΔipaB leaked induced overall MxiC leaked IpgD/IpaA leaked  
 
Wild-type NA ‒ +++ +++ ‒ +++++ ‒ ‒ NA NA NA 
ΔmxiC NA NA NA NA ‒ + +++ NA + 0 
Null 
(Translocators/ 
Effectors) 
ΔmxiC/mxiC NA ‒ +++ +++ ‒ ++++ ‒ ‒ ‒ NA NA 
mxiCΔCterm Cterm ND + + ‒ + +++ ‒/+ + 0 Near null 
mxiCΔNterm Nterm ‒ ‒ ‒ ‒ +++ +++ ND ND 1a MxiC/Effectors 
mxiCΔCBD CBD + ‒ +++ ‒ ++++ +++ ‒/+ + 1a MxiC/Effectors 
mxiCK66E CBD ++ ++a ND ‒ ++ +++ ‒ + 1b MxiC leaked/Effector 
mxiCK68E CBD +++ +++ ND ‒ ++ +++ ‒ ‒ 1c MxiC leaked 
mxiC(M226K,L242D; 
hydrophobic) hydro. ‒/+ +++ ND ‒ +++ +++ ‒/+ + 1d Effector 
mxiC(E201K,E276K, 
E293; negative) neg. ++ +++ ND +++
b ++++c ++ ‒/+ + 2 Translocators 
mxiC 
(I251A,T253A,S254A, 
D255E; straight) 
hinge ‒ +++ ND ‒ ++++d ‒ ND ND 2 Translocators 
mxiCV256P hinge ‒ + + ‒ +++ +++e ‒ + 1a MxiC/Effectors 
mxiC(T253G,S254G, 
D255G; wobble) hinge ‒ + ND ‒ ++ +++ ND ND 1a MxiC/Effectors 
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FIGURE LEGENDS 
 
FIGURE 1. Location of MxiC mutations used in this work. Top, MxiC structure 2VJ4 (chain A) coloured 
from blue at the N-terminus, where MxiC74 is the first residue in the first crystallised helix, to red at the 
C-terminus. Therefore N-terminus and most of CBD are not shown. Below, same MxiC rotated by 90° 
about its long axis. Mutated residues are coloured according to their design group, as labeled on the 
figure. In orange are mutations in the hydrophobic core of the protein, made by others (19,33), which lead 
to loss of function. 
 
FIGURE 2. MxiC without its secretion signal is still able to promote inducible translocator secretion. (A) 
Protein secretion in response to the artificial inducer Congo red (CR). Samples from Shigella wild-type, 
ΔmxiC mutant, complemented strain (ΔmxiC/mxiC+, grown with 25 µM IPTG) and mxiCΔNterm (in the 
ΔmxiC background, grown with 100 µM IPTG) were collected as described in the Experimental 
Procedures, Silver stained (top panel) and Western-blotted with the indicated antibodies (bottom panels). 
All samples probed with the same antibody were analysed on the same gel. Results shown are 
representative of at least two independent experiments. (B) Total protein expression levels in whole 
culture lysates. Samples were collected as described in the Experimental Procedures and Western-blotted 
with the indicated antibodies. (C) Quantification of translocator secretion after CR induction. Samples 
from two independent experiments, one of them performed in duplicate, were quantified on Western 
blots. The averages and standard deviations of the wild-type-normalised data are displayed. There is an 
overall difference between proteins and strains in an ANOVA (p < 0.01 and p < 0.001, respectively). In 
pairwise comparisons, the difference between ΔmxiC and both the complemented strain and mxiCΔNterm 
is statistically significant (post hoc test with Bonferroni correction, p < 0.001 and p < 0.01, respectively), 
while the difference between complemented strain and mxiCΔNterm is not significant. 
 
FIGURE 3. The putative chaperone-binding domain regulates MxiC secretion and is required for 
blocking effector secretion. (A) Protein secretion in response to the artificial inducer Congo red (CR). 
Samples from the complemented strain (ΔmxiC/mxiC+) and indicated mxiC mutants (in the ΔmxiC 
background) were collected as described in the Experimental Procedures, Silver-stained (top panel) and 
Western-blotted with the indicated antibodies (bottom panels). (B) Exponential leakage. Samples were 
collected as described in the Experimental Procedures, Silver-stained (top panel) and Western-blotted 
with the indicated antibodies (bottom panels). (C) Total protein expression levels in whole culture lysates. 
Samples were collected as described in the Experimental Procedures and Western-blotted with the 
indicated antibodies. Results shown are representative of at least two independent experiments. 
 
FIGURE 4. The conserved hydrophobic patch on the surface of MxiC is involved in preventing effector 
secretion. (A) Protein secretion in response to the artificial inducer Congo red (CR). Shigella wildtype, 
ΔmxiC mutant, complemented strain (ΔmxiC/mxiC+) and mxiC(M226K,L242D) (in the ΔmxiC 
background) were grown with 25 µM IPTG where required. Samples were collected as described in the 
Experimental Procedures, Silver-stained (top panel) and Western-blotted with the indicated antibodies 
(bottom panels). (B) Exponential leakage. Samples were collected as described in the Experimental 
Procedures, Silver-stained (top panel) and Western-blotted with the indicated antibodies (bottom panels). 
(C) Total protein expression levels in whole culture lysates. Samples were collected as described in the 
Experimental Procedures and Western-blotted with the indicated antibodies. Results shown are 
representative of at least two independent experiments. 
 
FIGURE 5. Mutants designed to alter the conformation of MxiC show opposed phenotypes. (A) Protein 
secretion in response to the artificial inducer Congo red (CR). Shigella wild-type, ΔmxiC mutant, 
complemented strain (ΔmxiC/mxiC+) and mxiC mutants (in the ΔmxiC background) were grown with 25 
µM IPTG where required. Mutant mxiC(T253G,S254G,D255G) is abbreviated mxiC(wobble) and mutant 
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mxiC(I251A,T253A,S254A,D255E) is abbreviated mxiC(straight). Samples were collected as described in 
the Experimental Procedures, Silver-stained (top panel) and Western-blotted with the indicated antibodies 
(bottom panels). (B) Exponential leakage. Samples were collected as described in the Experimental 
Procedures, Silver-stained (top panel) and Western-blotted with the indicated antibodies (bottom panels). 
(C) Total protein expression levels in whole culture lysates. Samples were collected as described in the 
Experimental Procedures and Western-blotted with the indicated antibodies. (D) Quantification of 
translocator secretion after CR induction. Samples from three independent experiments were quantified 
on Western blots and normalised against the complemented strain ΔmxiC/mxiC+. The averages and 
standard deviations are displayed. There is an overall difference between proteins and strains in an 
ANOVA (p < 0.01 and p < 0.001, respectively). In pairwise comparisons (post hoc test with Bonferroni 
correction), the difference between mxiC(T253G,S254G,D255G) and ΔmxiC/mxiC+ is statistically 
significant (p < 0.001), the same is true for mutant mxiCV256P. Both strains are not significantly different 
from the ΔmxiC mutant. Mutant mxiC(I251A, T253A,S254A,D255E) is overall significantly different from 
ΔmxiC (p < 0.001), but not from the complemented strain. There are also significant differences between 
proteins in the mxiC(I251A,T253A,S254A,D255E) mutant (p < 0.01 in an ANOVA). Specifically, IpaD is 
significantly different from both IpaB and IpaC (post hoc test with Bonferroni correction, p < 0.05  and p 
< 0.01, respectively). 
 
FIGURE 6. His-MxiC(Cys) is nearly completely labelled with MTSL and the 247-290 interspin distance 
distribution is between that of the “straight” and “bent” forms. His-MxiC(Cys) was modified with MTSL 
as described in Experimental Procedures. The labelling efficiency was assessed using room temperature 
continuous wave EPR. The resulting EPR derivative signal is displayed in arbitrary units (a.u.). (A) 
Labelling efficiency in His-MxiC(Cys) alone. The spin concentration is ca. 66 µM and ~100% of His-
MxiC(Cys) was modified by MTSL (the residual free label fraction is marked with an asterisk). (B) and 
(C) In the left column, V(t)/V(0) is the primary DEER data, the inset in B shows the background-
corrected F(t)/F(0) with the fit (red dotted line). In the right column, P(r) is the probability for the 
different distances extracted with model-free Tikhonov regularization using DeerAnalysis. The red dotted 
lines show the simulation by MMM. (B) Comparison of the “bent” MxiC model with the experimental 
data for His-MxiC(Cys). (C) Comparison of the MxiC crystal structure (PDB code 2VJ4, chain A) with 
the experimental data for His-MxiC(Cys). Comparisons with all other chains in all crystal structures are 
shown in supplemental Fig. S11. The chain presented in this panel was chosen because it was used as 
template to model the “bent” form of MxiC. 
 
FIGURE 7. Continuous wave EPR detects a weak but specific interaction of MxiC with IpaD. (A) 
Continuous wave (cw) EPR spectrum of spin-labeled MxiC in the absence (black) and in the presence of 
10-fold excess of Spa15 (cyan). (B) cw EPR spectrum of spin-labelled MxiC in the absence (black) and in 
the presence of 10-fold excess of IpgC (red) or IpgC-IpaC (orange). (C) Left, cw EPR spectrum of spin-
labelled MxiC in the absence (black) and in the presence of 10-fold excess of IpaD (green) or IpaD-
IpagC-IpaC (red). Right, the magnified low field region of the spectra (331.5-334.5 mT) highlights the 
detectable spectral differences. (D) Cw EPR spectrum of spin-labelled MxiC in the absence (black) in the 
absence (black) and in the presence of n-fold excess of IpaD (indicated in the legend). (E) Cw EPR 
spectrum of spin-labelled MxiC in the absence (black) and in the presence of 10-fold excess of IpaD 
(green), and after 1:4 dilution (olive green). The inset shows the magnified low field region of the spectra 
(331.5-334.5 mT) which highlights the fact that upon dilution, the spectrum reverts to that of MxiC alone 
(except for a small fraction of free label, see asterisks), indicating that complex formation can be detected 
only at high protein concentrations due to the low affinity. The normalisation of the spectral intensity of 
the diluted sample was done where indicated by the arrow to remove the effect of the free label. Except 
where otherwise stated, the spectra are normalised to the maximum amplitude of the central EPR line. 
The insets show the magnified low field region of the spectra (331.5-334.5 mT) to highlight possible 
spectral differences. The stars highlight the minor fraction of label, which is released during the 
incubation with some protein complexes and/or upon dilution. 
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FIGURE 8. Analysis of mxiC mutant phenotypes in the mxiHK69A background. Protein secretion in 
response to the artificial inducer Congo red (CR). Shigella wild-type, ΔmxiCΔmxiH mutant, 
complemented strains (ΔmxiCΔmxiH/mxiCmxiH or ΔmxiCΔmxiH/mxiCmxiHK69A) and mxiC mutants (in 
the ΔmxiCΔmxiH background expressing either mxiH or mxiHK69A) were grown with 25 µM IPTG 
where required. Mutants mxiC(E201K,E276K,E293) and mxiC(M226K,L242D) are abbreviated 
mxiC(negative) and mxiC(hydrophobic), respectively. Samples were collected as described in the 
Experimental Procedures, Silver-stained (top panel) and Western-blotted with the indicated antibodies 
(bottom panels). Arrow indicates faster migration of MxiC∆CBD. 
 
FIGURE 9. Modelling of MxiC-IpaD interaction. (A) Docking of gray MxiC (PDB entry 2VJ4 chain A 
(residues 64 – 349), (21), pink) and coloured IpaD (PDB entry 2J0O chain A, (42)). The N-terminal 
domain of IpaD is coloured in blue (residues 40-130), the C-terminal globular domain is coloured in red 
(residues 177-271) and the coiled coil domain is coloured in green (residues 131-176 and 272-321). 
Residues Glu201, Glu276 and Glu293 involved in the negatively charged patch of MxiC are highlight as 
space-fill model. The bottom panel is rotated 90 ° around the x-axis compared with the top panel 
illustrating the elongated shape of the dimer. (B) The interface of the MxiC IpaD dimer shows 
complementary charges. The top panel shows the electrostatic potential surface of IpaD and the backbone 
of MxiC, the bottom panel shows the electrostatic potential surface of MxiC and the backbone of IpaD. 
The panels are rotated 180° with respect to each other. Negative charges are shown in red, positive 
charges are depicted in blue. The docking was performed manually using the location of ipaD and mxiC 
mutants. The model was generated in Insight II 2005 and optimized using Discover 2.98. Electrostatic 
potential surfaces were calculated using Delphi (all Accelrys Inc.). 
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